Company Filing History:
Years Active: 2019
Title: The Innovative Contributions of Nicholas Impellitteri
Nicholas Impellitteri, based in Madison, Wisconsin, is a notable inventor known for his significant contributions to the field of biomedical engineering. With a focus on enhancing the safety and efficacy of blood products, his work exemplifies innovation that can make a real difference in clinical settings.
Latest Patents
Nicholas holds a patent for "Hydrogel microspheres containing peptide ligands for growth factor regulation in blood products." This patent describes vascular endothelial growth factor (VEGF)-sequestering hydrogel microspheres that are designed to selectively bind VEGF from blood products. Notably, one embodiment of this invention is utilized during intra-operative processes, allowing for the removal of the growth factor from blood products before they are administered in clinical procedures, which can greatly improve patient outcomes.
Career Highlights
Nicholas is associated with the Wisconsin Alumni Research Foundation, a prominent institution known for its dedication to advancing research and innovation. His role within this organization places him at the forefront of transformative healthcare technologies, where his work continues to push boundaries.
Collaborations
Working alongside colleagues David Belair and Ngoc Nhi Le, Nicholas has contributed to a collaborative environment that fosters creativity and innovation. Their combined efforts reflect a commitment to developing solutions that address critical healthcare challenges.
Conclusion
In conclusion, Nicholas Impellitteri's innovative work, particularly his patented technology involving hydrogel microspheres, has the potential to revolutionize the field of blood product management. His contributions, along with those of his collaborators at the Wisconsin Alumni Research Foundation, underscore the importance of research and innovation in improving clinical outcomes and patient care.